Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications
Open accessThe DOI matches its Crossref record; 215 of the 225 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC), a prevalent malignant tumor of the digestive system, ranks as the third and second in global incidence and mortality, respectively, in 2020, with 1.93 million new cases (≈10% of all cancers). There are 940,000 deaths (≈9.4% of all cancers), and the incidence of CRC in younger patients (under 50 years of age) has become a new trend. The pathogenesis of CRC is primarily attributed to a series of genetic and epigenetic abnormalities within normal colonic epithelial cells, coupled with the reshaping of the tumor microenvironment in the surrounding stroma. This process leads to the transformation of colorectal adenomas into invasive adenocarcinomas. Although genetic changes are known to be the primary driving force in the occurrence and progression of CRC, recent research indicates that epigenetic regulation serves as a crucial molecular marker in cancer, playing a significant role in the pathological and physiological control of interactions between genetics and the environment. This review discusses the current global epidemiology of CRC, its risk factors, and preventive treatment strategies. The current study explores the latest advancements in the epigenetic regulation of CRC, including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs). These developments hold potential as screening tools, prognostic biomarkers, and therapeutic targets for CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Moreover, alterations in histone acetylation and methylation can lead to changes in KRAS expression, and H3K9 and H3K27 methylation can repress EGFR transcription, thus leading to resistance against cetuximab [55].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [55]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Epigenetic alterations can affect the expression of genes involved in drug transport and several signaling pathways in CRC cells, such as cell proliferation, survival, apoptosis, and DNA repair [23,55].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–215 of 215
Qin, Y., Chen, X., Liu, Z., Tian, X., & Huo, Z. (2018) · Medical Science Monitor · doi:10.12659/msm.910016 · Cited by 19 · cited 1×
“Mechanistically, miR-106a is negatively correlated with DUSP2 in CRC tumor samples, and its elevation increases COX-2 and stem cell maintenance gene (SOX2 and OCT4) expression levels [136].”
BackgroundWang, J., Zhang, X., Zhang, J., Chen, S., Zhu, J., & Wang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02353-5 · Cited by 18 · cited 2×
“2 [178–182,”
BackgroundDong, W., Li, N., Pei, X., & Wu, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7881 · Cited by 18 · cited 1×
“The downregulation of DUSP2 induces carcinogenesis in CRC cells and increases CRC resistance to cetuximab [137].”
BackgroundYoshikawa, Y., Fukunaga, M., Takahashi, J., Shimizu, D., Masuda, T., Mizushima, T., Yamada, K., Mori, M., Eguchi, H., Doki, Y., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12355-w · Cited by 17
Boughanem, H., Martín‐Núñez, G. M., Torres, E., Arranz‐Salas, I., Alcaide, J., Morcillo, S., Tinahones, F. J., Crujeiras, A. B., & Macías‐González, M. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040219 · Cited by 14
Diagnostic Value of Combining miRNAs, CEA Measurement and the FOBT in Colorectal Cancer Screening
Li, X., Chen, R., Li, Z., Luo, B., Geng, W., & Wu, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s238492 · Cited by 14
Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer
Pan, X., Cheng, R., Zhu, X., Cai, F., Zheng, G., Li, J., & Gao, C. (2019) · Clinical Laboratory · doi:10.7754/clin.lab.2019.190412 · Cited by 13
Jiang, A. C., Buckingham, L. E., Bishehsari, F., Sutherland, S., Ma, K., & Melson, J. E. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000369 · Cited by 11 · cited 1×
“Therefore, low methylation and high expression of LINE-1 are conjectured to be associated with negative prognosis in CRC patients, with almost no heterogeneity in LINE-1 methylation within tumors [68–70].”
BackgroundXu, J., Wang, L., & Wang, Q. (2021) · Clinical Laboratory · doi:10.7754/clin.lab.2020.200805 · Cited by 7
Yang, M., Chen, W., Liu, H., Yu, L., Tang, M., & Liu, Y. (2022) · Molecular Biotechnology · doi:10.1007/s12033-021-00444-2 · Cited by 6 · cited 1×
“Consistently, downregulated lncRNA CBR3-AS1 potentially phagocytose mature miR-29a in the cytoplasm of CRC cells, consequently inhibiting miR-29a-mediated cell migration and invasion [185].”
BackgroundANRIL as a prognostic biomarker in colon pre-cancerous lesion detection via non-invasive sampling
Sadri, S., Rejali, L., Hadizadeh, M., Aghdaei, H. A., Young, C., Mojarad, E. N., Zali, M. R., & Bonab, M. A. (2021) · Genes & Genetic Systems · doi:10.1266/ggs.21-00102 · Cited by 6 · cited 1×
“This review summarizes common epigenetic biomarkers for CRC (see Figure 1), including the methylation of VIM, NDRG4, BMP3, SDC2, SEPT2, SEPT9 genes, and the high expression of miR-21, miR-135b-5p, miR-92a-1, ANRIL [215].”
BackgroundZhang, Y., Huang, W., Yuan, Y., Li, J., Wu, J., Yu, J., He, Y., Wei, Z., & Zhang, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01911-z · Cited by 4
Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer
Zhao, Y., Ren, Q. G., & Zhu, K. (2018) · Cancer Biomarkers · doi:10.3233/cbm-181246 · Cited by 4
E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis
Zhang, G., Zhang, Y., Chen, L., Liu, L., & Gao, X. (2023) · Cancer Insight · doi:10.58567/ci02010007 · Cited by 3 · cited 1×
“Furthermore, hypermethylation in promoter regions leads to the inactivation and dysfunction of multiple types of genes, including tumor suppressor genes such as PTCH1 and E-cadherin; DNA repair genes such as MLH1 and MGMT; and apoptosis-related genes such as Apaf1, Bcl2, and p53 [61–65].”
BackgroundRamesh, S., Johnson, P., Fadlalla, K., Moore, A., Huang, C.-H., Berry, K. L., Maxuitenko, Y. Y., Chen, X., Keeton, A. B., Zhou, G., et al. (2023) · Cancer Insight · doi:10.58567/ci02020003 · Cited by 3 · cited 1×
“For example, as the cancer suppressor gene Adenomatous Polyposis Coli (APC) exists in familial CRC and sporadic CRC (sCRC), it plays a key role in regulating the transcriptional activity of β - catenin [59].”
Background
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“Moreover, alterations in histone acetylation and methylation can lead to changes in KRAS expression, and H3K9 and H3K27 methylation can repress EGFR transcription, thus leading to resistance against cetuximab [55].”
Theodorakis, N., Feretzakis, G., Tzelves, L., Paxinou, E., Hitas, C., Vamvakou, G., Verykios, V. S., & Nikolaou, M. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090931 · Cited by 51
“ML algorithms can analyze epigenomic data to detect aberrant methylation patterns and predict which individuals might benefit from DNMT inhibitors [56].”
BackgroundKaviarasan, V., Das, A., Deka, D., Saha, B., Banerjee, A., Sharma, N. R., Duttaroy, A. K., & Pathak, S. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04790-w · Cited by 53
Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
Imran, K., Iqbal, M. J., Ahmed, M. M., Khalid, A., Cortés, H., Reyes‐Hernández, O. D., Figueroa‐González, G., Leyva‐Gómez, G., Falzone, L., Libra, M., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02905-z · Cited by 29
“Aberrant DNA methylation and miRNA dysregulation have been extensively studied in colorectal cancer [121, 122].”
Khan, A. H., Hasana, U., Nadeem, I. A., Khatri, S. P., Nawaz, S., Makhdoom, Q. U., Wazir, S., Patel, K., & Ghaly, M. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00277-z · Cited by 28
“Targeting lncRNAs and microbiota metabolites holds promise for CRC diagnosis and treatment, including second-generation multi-target stool RNA and DNA tests [44] .”
Metadata
- Authors
- Cao, Q., Tian, Y., Deng, Z., Yang, F., & Chen, E.
- Affiliations
- Northwest University (CN)
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an 710069, China
- Corresponding author
- Chen, Erfei
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-03-15
- Volume
- 25
- Issue
- 6
- Pages
- 3358
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10969857
- OpenAlex
- W4392865173
- Cited by
- 60
- References
- 225
- Citations by year
- 2026: 20 · 2025: 31 · 2024: 9
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Shaanxi Fundamental Science Research Project for Chemistry and Biology (22JHQ084)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- colorectal cancer, epigenetic regulation, DNA methylation, histone modifications, non-coding RNA, prognostic factors, cancer screening, tumor microenvironment, colorectal adenoma, cancer risk factors, cancer prevention, therapeutic target
- MeSH terms
- Humans, Prognosis, Colorectal Neoplasms, Biomarkers, DNA Methylation, Epigenesis, Genetic, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
